PDCD1 and glioblastoma: A six-gene prognostic model related to ubiquitination, SUMOylation, and neddylation and anti-PD-1 response is constructed in GBM, and the model exhibits excellent predictive properties in the clinical survival and drug sensitivity, which is benefit for accurate prediction and refined treatment in clinic.